SE0103819D0 - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- SE0103819D0 SE0103819D0 SE0103819A SE0103819A SE0103819D0 SE 0103819 D0 SE0103819 D0 SE 0103819D0 SE 0103819 A SE0103819 A SE 0103819A SE 0103819 A SE0103819 A SE 0103819A SE 0103819 D0 SE0103819 D0 SE 0103819D0
- Authority
- SE
- Sweden
- Prior art keywords
- chemical compounds
- compounds
- compositions
- preparing
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0103819A SE0103819D0 (sv) | 2001-11-15 | 2001-11-15 | Chemical compounds |
TW091132377A TW200407140A (en) | 2001-11-15 | 2002-11-01 | Chemical compounds |
US10/495,405 US20050014788A1 (en) | 2001-11-15 | 2002-11-12 | Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
CA002464861A CA2464861A1 (fr) | 2001-11-15 | 2002-11-12 | Derives de la piperidine et leurs utilisations comme modulateurs de l'activite du recepteur de la chemokine (specialement du ccr5) |
CNA028227409A CN1589261A (zh) | 2001-11-15 | 2002-11-12 | 哌啶衍生物及其作为趋化因子受体(尤其是ccr5)活性调节剂的用途 |
RU2004112781/04A RU2004112781A (ru) | 2001-11-15 | 2002-11-12 | Производные пиперидина и их применение в качестве модуляторов активности рецепторов хемокинов (в частности ccr5) |
KR10-2004-7007365A KR20050013526A (ko) | 2001-11-15 | 2002-11-12 | 피페리딘 유도체 및 그의 케모킨 수용체 활성의조절제로서의 용도 (특히 ccr5) |
PL02370910A PL370910A1 (en) | 2001-11-15 | 2002-11-12 | Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
PCT/SE2002/002054 WO2003042177A1 (fr) | 2001-11-15 | 2002-11-12 | Derives de la piperidine et leurs utilisations comme modulateurs de l'activite du recepteur de la chemokine (specialement du ccr5) |
MXPA04004497A MXPA04004497A (es) | 2001-11-15 | 2002-11-12 | Derivados de piperidina y su uso como moduladores de actividad del receptor de quimiocina (especialmente ccr5). |
HU0402567A HUP0402567A2 (hu) | 2001-11-15 | 2002-11-12 | Piperidinszármazékok és alkalmazásuk kemokin receptor (különösen CCR5) aktivitás modulátoraiként |
JP2003544013A JP2005513017A (ja) | 2001-11-15 | 2002-11-12 | ケモカイン受容体(特にccr)活性のモジュレーターとしてのピペリジン誘導体とその使用 |
EP02786316A EP1448524A1 (fr) | 2001-11-15 | 2002-11-12 | Derives de la piperidine et leurs utilisations comme modulateurs de l'activite du recepteur de la chemokine (specialement du ccr5) |
BR0214141-8A BR0214141A (pt) | 2001-11-15 | 2002-11-12 | Derivados de piperidina e seu uso como moduladores da atividade de receptor de quimiocina (especialmente ccr5) |
IL16159402A IL161594A0 (en) | 2001-11-15 | 2002-11-12 | Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
ARP020104332A AR037350A1 (es) | 2001-11-15 | 2002-11-12 | Derivados de piperidina, proceso para preparar estos compuestos, composicion farmaceutica, y uso de estos compuestos para la manufactura de un medicamento util para el tratamiento de una enfermedad mediada por ccr5 (tal como artritis reumatoidea) |
IS7257A IS7257A (is) | 2001-11-15 | 2004-05-10 | Píperidínafleiður og notkun þeirra sem stilla á virkni flakkboðaviðtaka (einkum CCR5) |
ZA200403681A ZA200403681B (en) | 2001-11-15 | 2004-05-13 | Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5). |
NO20042156A NO20042156L (no) | 2001-11-15 | 2004-05-25 | Piperidinderivater og deres anvendelse som modulatorer av kemokinreseptoraktivitet (spesielt CCRS) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0103819A SE0103819D0 (sv) | 2001-11-15 | 2001-11-15 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0103819D0 true SE0103819D0 (sv) | 2001-11-15 |
Family
ID=20286006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0103819A SE0103819D0 (sv) | 2001-11-15 | 2001-11-15 | Chemical compounds |
Country Status (19)
Country | Link |
---|---|
US (1) | US20050014788A1 (fr) |
EP (1) | EP1448524A1 (fr) |
JP (1) | JP2005513017A (fr) |
KR (1) | KR20050013526A (fr) |
CN (1) | CN1589261A (fr) |
AR (1) | AR037350A1 (fr) |
BR (1) | BR0214141A (fr) |
CA (1) | CA2464861A1 (fr) |
HU (1) | HUP0402567A2 (fr) |
IL (1) | IL161594A0 (fr) |
IS (1) | IS7257A (fr) |
MX (1) | MXPA04004497A (fr) |
NO (1) | NO20042156L (fr) |
PL (1) | PL370910A1 (fr) |
RU (1) | RU2004112781A (fr) |
SE (1) | SE0103819D0 (fr) |
TW (1) | TW200407140A (fr) |
WO (1) | WO2003042177A1 (fr) |
ZA (1) | ZA200403681B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0104050D0 (en) | 2001-02-19 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
SE0202483D0 (sv) * | 2002-08-21 | 2002-08-21 | Astrazeneca Ab | Chemical compounds |
SE0301369D0 (sv) * | 2003-05-09 | 2003-05-09 | Astrazeneca Ab | Chemical compounds |
SE0302090D0 (sv) * | 2003-07-16 | 2003-07-16 | Astrazeneca Ab | Chemical compounds |
ES2285485T3 (es) * | 2003-07-31 | 2007-11-16 | Astrazeneca Ab | Derivados de piperidina como moduladores del receptor ccr5. |
EP1786816A4 (fr) | 2003-09-10 | 2009-11-04 | Virochem Pharma Inc | Composes de spirohydantoine et procedes de modulation de l'activite des recepteurs de chimiokine |
SE0303396D0 (sv) * | 2003-12-16 | 2003-12-16 | Astrazeneca Ab | Chemical compounds |
KR100905260B1 (ko) | 2004-06-09 | 2009-06-30 | 상해 타킷 드러그 주식회사 | 씨씨알5 길항제로서의 화합물 |
CN1329374C (zh) * | 2004-06-09 | 2007-08-01 | 上海靶点药物有限公司 | 作为ccr5拮抗剂的化合物 |
SE0401656D0 (sv) * | 2004-06-24 | 2004-06-24 | Astrazeneca Ab | Chemical compounds |
SE0403084D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Chemical process |
JP2009525269A (ja) | 2006-01-30 | 2009-07-09 | ユーロ−セルティーク エス.エイ. | カルシウムチャネルブロッカーとしての環状尿素化合物 |
GB0625523D0 (en) * | 2006-12-21 | 2007-01-31 | Ge Healthcare Ltd | In vivo imaging agents |
WO2009010478A2 (fr) * | 2007-07-13 | 2009-01-22 | Euroscreen S.A. | Utilisation de dérivés de pipéridine en tant qu'agonistes de l'activité des récepteurs de la chimiokine |
CN105579555A (zh) * | 2013-09-25 | 2016-05-11 | 默克专利股份有限公司 | 化合物和介晶介质 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1279668A (zh) * | 1997-11-18 | 2001-01-10 | 帝人株式会社 | 环胺衍生物及其作为药物的用途 |
EP1013276A1 (fr) * | 1998-12-23 | 2000-06-28 | Pfizer Inc. | Aminoazacycloalcanes comme modulateurs de CCR5 |
SE9902987D0 (sv) * | 1999-08-24 | 1999-08-24 | Astra Pharma Prod | Novel compounds |
GB0011838D0 (en) * | 2000-05-17 | 2000-07-05 | Astrazeneca Ab | Chemical compounds |
-
2001
- 2001-11-15 SE SE0103819A patent/SE0103819D0/xx unknown
-
2002
- 2002-11-01 TW TW091132377A patent/TW200407140A/zh unknown
- 2002-11-12 AR ARP020104332A patent/AR037350A1/es unknown
- 2002-11-12 CN CNA028227409A patent/CN1589261A/zh active Pending
- 2002-11-12 KR KR10-2004-7007365A patent/KR20050013526A/ko not_active Application Discontinuation
- 2002-11-12 MX MXPA04004497A patent/MXPA04004497A/es unknown
- 2002-11-12 JP JP2003544013A patent/JP2005513017A/ja active Pending
- 2002-11-12 HU HU0402567A patent/HUP0402567A2/hu unknown
- 2002-11-12 CA CA002464861A patent/CA2464861A1/fr not_active Abandoned
- 2002-11-12 WO PCT/SE2002/002054 patent/WO2003042177A1/fr active Application Filing
- 2002-11-12 US US10/495,405 patent/US20050014788A1/en not_active Abandoned
- 2002-11-12 BR BR0214141-8A patent/BR0214141A/pt not_active IP Right Cessation
- 2002-11-12 EP EP02786316A patent/EP1448524A1/fr not_active Withdrawn
- 2002-11-12 RU RU2004112781/04A patent/RU2004112781A/ru not_active Application Discontinuation
- 2002-11-12 IL IL16159402A patent/IL161594A0/xx unknown
- 2002-11-12 PL PL02370910A patent/PL370910A1/xx not_active Application Discontinuation
-
2004
- 2004-05-10 IS IS7257A patent/IS7257A/is unknown
- 2004-05-13 ZA ZA200403681A patent/ZA200403681B/en unknown
- 2004-05-25 NO NO20042156A patent/NO20042156L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2005513017A (ja) | 2005-05-12 |
IL161594A0 (en) | 2004-09-27 |
US20050014788A1 (en) | 2005-01-20 |
WO2003042177A1 (fr) | 2003-05-22 |
RU2004112781A (ru) | 2005-10-10 |
AR037350A1 (es) | 2004-11-03 |
PL370910A1 (en) | 2005-05-30 |
CN1589261A (zh) | 2005-03-02 |
MXPA04004497A (es) | 2004-08-11 |
IS7257A (is) | 2004-05-10 |
TW200407140A (en) | 2004-05-16 |
NO20042156L (no) | 2004-08-11 |
ZA200403681B (en) | 2005-08-02 |
CA2464861A1 (fr) | 2003-05-22 |
EP1448524A1 (fr) | 2004-08-25 |
KR20050013526A (ko) | 2005-02-04 |
HUP0402567A2 (hu) | 2005-03-29 |
WO2003042177A8 (fr) | 2005-01-06 |
BR0214141A (pt) | 2004-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200610761A (en) | Chemical compounds | |
TW200630326A (en) | Chemical compounds | |
MXPA02011304A (es) | Derivados de piperidina farmaceuticamente activos, en partiular como moduladores de la actividad del receptor de la quimocina. | |
SE0103818D0 (sv) | Chemical compounds | |
TW200630352A (en) | Chemical compounds | |
SE0103819D0 (sv) | Chemical compounds | |
TW200610759A (en) | Chemical compounds | |
TW200505856A (en) | Chemical compounds | |
SE0101387D0 (sv) | Novel compounds | |
SE9904505D0 (sv) | Novel compounds | |
MXPA04004601A (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
TNSN04203A1 (en) | Benzoxazinone-derived compounds, their preparation and use as medicaments | |
SE9902765D0 (sv) | Novel compounds | |
SE0401656D0 (sv) | Chemical compounds | |
SE0301369D0 (sv) | Chemical compounds | |
DE60201259D1 (de) | Chemische verbindungen | |
SE0203828D0 (sv) | Chemical compounds | |
SE0203820D0 (sv) | chemical compounds | |
UA83832C2 (ru) | Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и их применение | |
SE0302090D0 (sv) | Chemical compounds | |
SE0303396D0 (sv) | Chemical compounds | |
TW200510307A (en) | Chemical compounds | |
DE60114597D1 (de) | Naphthamid-neurokinin antagonisten zur verwendung als medikamente | |
SE0402636D0 (sv) | Chemical compounds | |
SE0401057D0 (sv) | Chemical Compounds |